These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34994382)

  • 21. Myc and E2F1 induce p53 through p14ARF-independent mechanisms in human fibroblasts.
    Lindström MS; Wiman KG
    Oncogene; 2003 Aug; 22(32):4993-5005. PubMed ID: 12902982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p19(ARF) is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo.
    Tolbert D; Lu X; Yin C; Tantama M; Van Dyke T
    Mol Cell Biol; 2002 Jan; 22(1):370-7. PubMed ID: 11739748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stress-regulated transcription factor ATF4 promotes neoplastic transformation by suppressing expression of the INK4a/ARF cell senescence factors.
    Horiguchi M; Koyanagi S; Okamoto A; Suzuki SO; Matsunaga N; Ohdo S
    Cancer Res; 2012 Jan; 72(2):395-401. PubMed ID: 22102693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential p53-independent outcomes of p19(Arf) loss in oncogenesis.
    Chen Z; Carracedo A; Lin HK; Koutcher JA; Behrendt N; Egia A; Alimonti A; Carver BS; Gerald W; Teruya-Feldstein J; Loda M; Pandolfi PP
    Sci Signal; 2009 Aug; 2(84):ra44. PubMed ID: 19690330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncogenic c-Myc-induced lymphomagenesis is inhibited non-redundantly by the p19Arf-Mdm2-p53 and RP-Mdm2-p53 pathways.
    Meng X; Carlson NR; Dong J; Zhang Y
    Oncogene; 2015 Nov; 34(46):5709-17. PubMed ID: 25823025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance of primary cultured mouse hepatic tumor cells to cellular senescence despite expression of p16(Ink4a), p19(Arf), p53, and p21(Waf1/Cip1).
    Obata M; Imamura E; Yoshida Y; Goto J; Kishibe K; Yasuda A; Ogawa K
    Mol Carcinog; 2001 Sep; 32(1):9-18. PubMed ID: 11568971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncogenic ras and p53 cooperate to induce cellular senescence.
    Ferbeyre G; de Stanchina E; Lin AW; Querido E; McCurrach ME; Hannon GJ; Lowe SW
    Mol Cell Biol; 2002 May; 22(10):3497-508. PubMed ID: 11971980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rho family GTPases cooperate with p53 deletion to promote primary mouse embryonic fibroblast cell invasion.
    Guo F; Zheng Y
    Oncogene; 2004 Jul; 23(33):5577-85. PubMed ID: 15122327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C/EBPbeta cooperates with RB:E2F to implement Ras(V12)-induced cellular senescence.
    Sebastian T; Malik R; Thomas S; Sage J; Johnson PF
    EMBO J; 2005 Sep; 24(18):3301-12. PubMed ID: 16107878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oncogenic Ras induces p19ARF and growth arrest in mouse embryo fibroblasts lacking p21Cip1 and p27Kip1 without activating cyclin D-dependent kinases.
    Groth A; Weber JD; Willumsen BM; Sherr CJ; Roussel MF
    J Biol Chem; 2000 Sep; 275(35):27473-80. PubMed ID: 10842176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ubiquitination of, and sumoylation by, the Arf tumor suppressor.
    den Besten W; Kuo ML; Tago K; Williams RT; Sherr CJ
    Isr Med Assoc J; 2006 Apr; 8(4):249-51. PubMed ID: 16671360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific contribution of p19(ARF) to nitric oxide-dependent apoptosis.
    Zeini M; Través PG; López-Fontal R; Pantoja C; Matheu A; Serrano M; Boscá L; Hortelano S
    J Immunol; 2006 Sep; 177(5):3327-36. PubMed ID: 16920973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Escape from premature senescence is not sufficient for oncogenic transformation by Ras.
    Peeper DS; Dannenberg JH; Douma S; te Riele H; Bernards R
    Nat Cell Biol; 2001 Feb; 3(2):198-203. PubMed ID: 11175753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
    Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
    Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RasV12-mediated down-regulation of CCAAT/enhancer binding protein beta in immortalized fibroblasts requires loss of p19Arf and facilitates bypass of oncogene-induced senescence.
    Sebastian T; Johnson PF
    Cancer Res; 2009 Mar; 69(6):2588-98. PubMed ID: 19276382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Roles of ARF tumour suppressor protein in lung cancer: time to hit the nail on the head!
    Vashi R; Patel BM
    Mol Cell Biochem; 2021 Mar; 476(3):1365-1375. PubMed ID: 33392921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation.
    Raveh T; Droguett G; Horwitz MS; DePinho RA; Kimchi A
    Nat Cell Biol; 2001 Jan; 3(1):1-7. PubMed ID: 11146619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The tumor-suppressive functions of the human INK4A locus.
    Voorhoeve PM; Agami R
    Cancer Cell; 2003 Oct; 4(4):311-9. PubMed ID: 14585358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer-associated mutations at the INK4a locus cancel cell cycle arrest by p16INK4a but not by the alternative reading frame protein p19ARF.
    Quelle DE; Cheng M; Ashmun RA; Sherr CJ
    Proc Natl Acad Sci U S A; 1997 Jan; 94(2):669-73. PubMed ID: 9012842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Cdkn2a gene product p19 alternative reading frame (p19ARF) is a critical regulator of IFNβ-mediated Lyme arthritis.
    Li J; Ma Y; Paquette JK; Richards AC; Mulvey MA; Zachary JF; Teuscher C; Weis JJ
    PLoS Pathog; 2022 Mar; 18(3):e1010365. PubMed ID: 35324997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.